BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 29431745)

  • 1. DKK2 imparts tumor immunity evasion through β-catenin-independent suppression of cytotoxic immune-cell activation.
    Xiao Q; Wu J; Wang WJ; Chen S; Zheng Y; Yu X; Meeth K; Sahraei M; Bothwell ALM; Chen L; Bosenberg M; Chen J; Sexl V; Sun L; Li L; Tang W; Wu D
    Nat Med; 2018 Mar; 24(3):262-270. PubMed ID: 29431745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer.
    Cen B; Wei J; Wang D; Xiong Y; Shay JW; DuBois RN
    Oncogene; 2021 Oct; 40(41):5984-5992. PubMed ID: 34385594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dickkopf-Related Protein 2 is Epigenetically Inactivated and Suppresses Colorectal Cancer Growth and Tumor Metastasis by Antagonizing Wnt/β-Catenin Signaling.
    Wang C; Yue Y; Shao B; Qiu Z; Mu J; Tang J; Han X; Xiang T; Ren G
    Cell Physiol Biochem; 2017; 41(5):1709-1724. PubMed ID: 28365691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer.
    Sui Q; Liu D; Jiang W; Tang J; Kong L; Han K; Liao L; Li Y; Ou Q; Xiao B; Liu G; Ling Y; Chen J; Liu Z; Zuo Z; Pan Z; Zhou P; Zheng J; Ding PR
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33782107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DKK2 blockage-mediated immunotherapy enhances anti-angiogenic therapy of Kras mutated colorectal cancer.
    Hu J; Wang Z; Chen Z; Li A; Sun J; Zheng M; Wu J; Shen T; Qiao J; Li L; Li B; Wu D; Xiao Q
    Biomed Pharmacother; 2020 Jul; 127():110229. PubMed ID: 32559853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic β-catenin signaling suppresses CD8
    Xue J; Yu X; Xue L; Ge X; Zhao W; Peng W
    Biomed Pharmacother; 2019 Jul; 115():108921. PubMed ID: 31078045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer.
    Li Y; Lauriola M; Kim D; Francesconi M; D'Uva G; Shibata D; Malafa MP; Yeatman TJ; Coppola D; Solmi R; Cheng JQ
    Oncogene; 2016 Sep; 35(35):4558-4568. PubMed ID: 26804172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer group 2D receptor and its ligands in cancer immune escape.
    Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F
    Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models.
    Waaler J; Mygland L; Tveita A; Strand MF; Solberg NT; Olsen PA; Aizenshtadt A; Fauskanger M; Lund K; Brinch SA; Lycke M; Dybing E; Nygaard V; Bøe SL; Heintz KM; Hovig E; Hammarström C; Corthay A; Krauss S
    Commun Biol; 2020 Apr; 3(1):196. PubMed ID: 32332858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion.
    Du L; Lee JH; Jiang H; Wang C; Wang S; Zheng Z; Shao F; Xu D; Xia Y; Li J; Zheng Y; Qian X; Li X; Kim HR; Xing D; Liu P; Lu Z; Lyu J
    J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32860047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer.
    Giordano G; Parcesepe P; D'Andrea MR; Coppola L; Di Raimo T; Remo A; Manfrin E; Fiorini C; Scarpa A; Amoreo CA; Conciatori F; Milella M; Caruso FP; Cerulo L; Porras A; Pancione M
    J Exp Clin Cancer Res; 2019 Jan; 38(1):28. PubMed ID: 30670049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer.
    Liao W; Overman MJ; Boutin AT; Shang X; Zhao D; Dey P; Li J; Wang G; Lan Z; Li J; Tang M; Jiang S; Ma X; Chen P; Katkhuda R; Korphaisarn K; Chakravarti D; Chang A; Spring DJ; Chang Q; Zhang J; Maru DM; Maeda DY; Zebala JA; Kopetz S; Wang YA; DePinho RA
    Cancer Cell; 2019 Apr; 35(4):559-572.e7. PubMed ID: 30905761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary resistance to immunotherapy associated with β-catenin pathway activation or PTEN loss in metastatic melanoma.
    Trujillo JA; Luke JJ; Zha Y; Segal JP; Ritterhouse LL; Spranger S; Matijevich K; Gajewski TF
    J Immunother Cancer; 2019 Nov; 7(1):295. PubMed ID: 31703593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In situ analyses of molecular mechanisms of colorectal carcinogenesis].
    Kriegl L
    Pathologe; 2013 Nov; 34 Suppl 2():269-73. PubMed ID: 24196627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer.
    Mu J; Hui T; Shao B; Li L; Du Z; Lu L; Ye L; Li S; Li Q; Xiao Q; Qiu Z; Zhang Y; Fan J; Ren G; Tao Q; Xiang T
    Oncotarget; 2017 Jun; 8(24):39443-39459. PubMed ID: 28467796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic alterations of the APC gene in malignant melanoma.
    Worm J; Christensen C; Grønbaek K; Tulchinsky E; Guldberg P
    Oncogene; 2004 Jul; 23(30):5215-26. PubMed ID: 15133491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion.
    Freeman AJ; Vervoort SJ; Ramsbottom KM; Kelly MJ; Michie J; Pijpers L; Johnstone RW; Kearney CJ; Oliaro J
    Cell Rep; 2019 Sep; 28(11):2784-2794.e5. PubMed ID: 31509742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
    Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
    Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability.
    Thorstensen L; Lind GE; Løvig T; Diep CB; Meling GI; Rognum TO; Lothe RA
    Neoplasia; 2005 Feb; 7(2):99-108. PubMed ID: 15802015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.